Business
Light AI reports Financial Results for Three Months and Year ended December 31, 2025
Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a digital healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic solutions, today announced its financial and operating results for its fourth quarter of 2025 representing the three months and year ended December 31, 2025. Financial information is reported in Canadian dollars ("$") unless otherwise stated and in accordance with International Financial Reporting Sta
About this update from Light Ai Inc.
[{"type":"text","content":"VANCOUVER, BC, March 26, 2026 /CNW/ - Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a digital healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic solutions, today announced its financial and operating results for its fourth quarter of 2025 representing the three months and year ended December 31, 2025. Financial information is reported in Canadian dollars ("$") unless otherwise stated and in accordance with International Financial Reporting Standards ("IFRS").","length":609,"tagName":"p"},{"type":"text","content":"Financial and Operating Results Summary for the three months and year ended December 31, 2025 ","length":94,"tagName":"p"},{"type":"text","content":"The Company is currently in the clinical trial and regulatory stage of its software as a medical device (SaMD) technology offering with anticipated commercialization initiatives commencing in Q3-Q4 2026 pending successful regulatory approvals. During the three months ended December 31, 2025, the Company had total operating expenses, inclusive of interest, depreciation and non-cash-based share compensation expense, of $2.3 million compared to $5.6 million for the three months ended September 30, 2025 and $2.4 million for the three months ended December 31, 2024. The decline in total operating expense for the three months ended December 31, 2025 over the prior period is primarily attributable to lower marketing expenses, product development expenses and non-share-based compensation. The Company had total operating expenses, inclusive of depreciation and non-cash-based share compensation expense of $4.3 million, of $16.1 million for the year ended December 31, 2025 which increased from $8.1 million in the prior year due primarily to increased marketing and investor relations expenses as a result of becoming a public company during 2025 in addition to increased product development costs.","length":1202,"tagName":"p"},{"type":"text","content":"The Company had cash of $6.5 million with total assets of $6.9 million as at December 31, 2025 compared to cash of $15.2 million with total assets of $17.1 million as at December 31, 2024. On January 8, 2025, the Company closed the second of two tranches of the Offering by issuing 2,757,000 units...